Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Warts × Cidofovir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Squamous Intraepithelial Lesions 2 Warts 1 Sarcoma, Kaposi 1 Sarcoma 1 Precancerous Conditions 1 Anus Neoplasms 1 AIDS-related Kaposi sarcoma 1

Interventions

resiquimod 6 lactic acid, salicylic acid drug combination 1 human papillomavirus vaccine, L1 type 16, 18 1 VP-102 1 Sugars 1 PRA1 protein, Candida albicans 1 Nitric Oxide 1 Maltose 1 Interferon-alpha 1 Cidofovir 1 Cholecalciferol 1 Cantharidin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02567149 2017-07-02

Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.

University of Minnesota

Phase 2 Withdrawn

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡